Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Sonnet BioTherapeutics (SONN)

Annual Return

Over the past 3 years, SONN has had an average annual return of +0%, underperforming the benchmark SPY, which returned +22.19% annual.

Over the past 5 years, SONN has had an average annual return of -68.25%, underperforming the benchmark SPY, which returned +12.82% annual.

Over the past 10 years, SONN has had an average annual return of -60.49%, underperforming the benchmark SPY, which returned +15.02% annual.

Since Oct 31, 2006, SONN has had an average annual return of -43.74%, underperforming the benchmark SPY, which returned +10.77% annual.

202220212020201920182017201620152014201320122011
+0%-85.71%-85.11%-54.37%-50.95%-37.50%-58.00%-42.03%-67.88%+47.53%-50.81%+74.12%
20102009200820072006
+6.25%-30.43%+10.58%-52.73%-12.00%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2022+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%
2021+14.29%-12.50%+0%+0%-28.57%+0%-40.00%-33.33%+0%+0%+0%-50.00%-85.71%
2020+8.51%-39.22%+3.23%-50.00%-18.75%-15.38%+18.18%-38.46%+0%+0%+0%-12.50%-85.11%
2019+53.40%-6.96%-6.12%-14.49%-22.88%-3.30%-31.82%-23.33%+26.09%+5.17%-18.03%-6.00%-54.37%
2018+45.71%-1.31%-1.99%-7.77%-11.36%+2.07%-10.93%-5.45%-4.81%-18.18%-9.88%-29.45%-50.95%
2017-2.38%+2.44%-14.29%-16.67%-5.83%+10.62%-6.40%-22.65%+15.47%-16.27%+24.57%-3.67%-37.50%

Drawdown analysis of Sonnet BioTherapeutics (SONN)

The maximum drawdown for the SONN was -99.99%, occurring on Dec 3, 2021. This drawdown has not yet recovered.

The current SONN drawdown is -99.99%.

Since Oct 31, 2006 SONN has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Oct 31, 20063799Dec 3, 2021OngoingOngoingOngoing